Diagnostics & Research
The Diagnostics & Research industry has a total of 49 stocks, with a combined market cap of $724.23 billion, total revenue of $168.76 billion and a weighted average PE ratio of 45.14.
Market Cap
724.23B
Revenue
168.76B
Profits
16.04B
PE Ratio
45.14
Profit Margin
9.51%
Dividend Yield
0.22%
49 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | TMO | Thermo Fisher Scientific Inc. | 189.66B | -0.98% | 3,188,086 | 44.56B |
| 2 | DHR | Danaher Corporation | 150.27B | -1.10% | 5,286,211 | 24.57B |
| 3 | IDXX | IDEXX Laboratories, Inc. | 50.25B | 1.97% | 537,917 | 4.30B |
| 4 | A | Agilent Technologies, Inc. | 35.58B | 0.74% | 1,527,812 | 6.95B |
| 5 | WAT | Waters Corporation | 31.72B | 1.11% | 2,532,351 | 3.17B |
| 6 | NTRA | Natera, Inc. | 28.53B | -0.77% | 790,439 | 2.12B |
| 7 | IQV | IQVIA Holdings Inc. | 28.31B | -1.13% | 4,265,518 | 16.31B |
| 8 | MTD | Mettler-Toledo International Inc. | 27.66B | 0.22% | 156,161 | 4.03B |
| 9 | LH | Labcorp Holdings Inc. | 23.43B | 1.63% | 702,486 | 13.77B |
| 10 | DGX | Quest Diagnostics Incorporated | 22.76B | - | 1,354,595 | 11.04B |
| 11 | EXAS | Exact Sciences Corporation | 19.71B | 0.01% | 2,120,398 | 3.25B |
| 12 | ILMN | Illumina, Inc. | 17.86B | 2.07% | 1,866,921 | 4.34B |
| 13 | GH | Guardant Health, Inc. | 13.51B | 2.03% | 892,232 | 902.57M |
| 14 | MEDP | Medpace Holdings, Inc. | 12.15B | 2.88% | 672,732 | 2.53B |
| 15 | RVTY | Revvity, Inc. | 10.89B | 0.48% | 1,471,003 | 2.86B |
| 16 | QGEN | Qiagen N.V. | 10.39B | -0.87% | 2,508,918 | 2.09B |
| 17 | CRL | Charles River Laboratories International, Inc. | 7.94B | 1.64% | 1,102,265 | 4.02B |
| 18 | ICLR | ICON Public Limited Company | 7.10B | 16.13% | 14,016,780 | 8.10B |
| 19 | RDNT | RadNet, Inc. | 5.38B | 6.59% | 680,814 | 1.97B |
| 20 | SHC | Sotera Health Company | 4.86B | 0.88% | 1,580,176 | 1.15B |
| 21 | BLLN | BillionToOne, Inc. | 4.06B | -0.72% | 146,483 | 254.14M |
| 22 | GRAL | GRAIL, Inc. | 3.80B | 1.68% | 441,515 | 141.83M |
| 23 | TWST | Twist Bioscience Corporation | 3.01B | 3.04% | 1,063,343 | 391.56M |
| 24 | VCYT | Veracyte, Inc. | 2.83B | 1.85% | 653,885 | 495.14M |
| 25 | WGS | GeneDx Holdings Corp. | 2.61B | -0.57% | 627,843 | 402.19M |
| 26 | NEOG | Neogen Corporation | 2.38B | 1.48% | 4,275,986 | 880.32M |
| 27 | NEO | NeoGenomics, Inc. | 1.47B | 1.97% | 2,620,739 | 709.16M |
| 28 | CDNA | CareDx, Inc. | 1.01B | 2.77% | 463,937 | 358.00M |
| 29 | CSTL | Castle Biosciences, Inc. | 967.60M | 4.01% | 242,879 | 343.53M |
| 30 | OPK | OPKO Health, Inc. | 944.27M | 1.65% | 2,144,684 | 642.07M |
| 31 | PSNL | Personalis, Inc. | 729.08M | -2.15% | 735,024 | 69.10M |
| 32 | FLGT | Fulgent Genetics, Inc. | 724.28M | 2.00% | 161,065 | 315.55M |
| 33 | MYGN | Myriad Genetics, Inc. | 418.53M | -0.88% | 1,035,608 | 825.30M |
| 34 | PRE | Prenetics Global Limited | 369.72M | 4.82% | 112,227 | 77.08M |
| 35 | BNR | Burning Rock Biotech Limited | 313.68M | -3.75% | 13,635 | 75.75M |
| 36 | IMDX | Insight Molecular Diagnostics Inc. | 179.06M | 0.90% | 72,373 | 4.40M |
| 37 | MDXH | MDxHealth SA | 168.29M | -0.58% | 118,947 | 103.07M |
| 38 | FONR | FONAR Corporation | 121.53M | - | 79,225 | 106.03M |
| 39 | BDSX | Biodesix, Inc. | 91.09M | 5.63% | 332,314 | 80.17M |
| 40 | XGN | Exagen Inc. | 74.33M | 1.39% | 235,798 | 63.60M |
| 41 | PRPO | Precipio, Inc. | 40.98M | 4.33% | 23,615 | 22.80M |
| 42 | MBAI | Check-Cap Ltd. | 13.41M | 1.10% | 72,702 | - |
| 43 | NOTV | Inotiv, Inc. | 9.80M | -1.86% | 678,644 | 514.03M |
| 44 | MYNZ | Mainz Biomed N.V. | 8.64M | 6.52% | 55,052 | 659.94K |
| 45 | ADVB | Advanced Biomed Inc. | 6.55M | 1.09% | 28,499 | - |
| 46 | BIAF | bioAffinity Technologies, Inc. | 4.67M | -5.45% | 195,153 | 6.78M |
| 47 | NDRA | ENDRA Life Sciences Inc. | 4.09M | -1.68% | 23,958 | - |
| 48 | ISPC | iSpecimen Inc. | 2.96M | -4.84% | 2,438,417 | 3.35M |
| 49 | XWEL | XWELL, Inc. | 2.55M | -5.88% | 222,891 | 29.52M |